Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
Author(s) -
Constantine E. Kosmas,
Maria D. Bousvarou,
Andreas Sourlas,
E Papakonstantinou,
Edilberto Peña Genao,
Rogers Echavarria Uceta,
Eliscer Guzman
Publication year - 2022
Publication title -
clinical pharmacology advances and applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.685
H-Index - 27
ISSN - 1179-1438
DOI - 10.2147/cpaa.s345072
Subject(s) - pcsk9 , ezetimibe , medicine , pharmacology , lipoprotein lipase , microsomal triglyceride transfer protein , endocrinology , proprotein convertase , cholesterol , lipoprotein , very low density lipoprotein , ldl receptor , adipose tissue
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom